Phosphoinositide-Dependent Kinase 1 Provides Negative Feedback Inhibition to Toll-Like Receptor-Mediated NF-κB Activation in Macrophages

REFERENCES

• Akira, S. 2003. Toll-like receptor signaling. J. Biol. Chem. 278:38105–38108.
   PubMed Web of Science ®Google Scholar
• Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499–511.
   PubMed Web of Science ®Google Scholar
• Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675–680.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. Reese, and P. Cohen. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7:261–269.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and A. S. Baldwin, Jr. 1993. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064–2070.
   PubMed Web of Science ®Google Scholar
• Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871.
   PubMed Web of Science ®Google Scholar
• Bonizzi, G., and M. Karin. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280–288.
   PubMed Web of Science ®Google Scholar
• Boone, D. L., E. E. Turer, E. G. Lee, R. C. Ahmad, M. T. Wheeler, C. Tsui, P. Hurley, M. Chien, S. Chai, O. Hitotsumatsu, E. McNally, C. Pickart, and A. Ma. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5:1052–1060.
   PubMed Web of Science ®Google Scholar
• Brüning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
   PubMed Web of Science ®Google Scholar
• Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443–446.
   PubMed Web of Science ®Google Scholar
• Carrière, A., M. Cargnello, L. A. Julien, H. Gao, E. Bonneil, P. Thibault, and P. P. Roux. 2008. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr. Biol. 18:1269–1277.
   PubMed Web of Science ®Google Scholar
• Chandra, R., E. Villanueva, E. Feketova, G. W. Machiedo, G. Hasko, E. A. Deitch, and Z. Spolarics. 2008. Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency. J. Leukoc. Biol. 83:1541–1550.
   PubMedGoogle Scholar
• Chen, H., Y. Wu, Y. Zhang, L. Jin, L. Luo, B. Xue, C. Lu, X. Zhang, and Z. Yin. 2006. Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett. 580:3145–3152.
   PubMed Web of Science ®Google Scholar
• Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Forster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277.
   PubMed Web of Science ®Google Scholar
• Danner, R. L., R. J. Elin, J. M. Hosseini, R. A. Wesley, J. M. Reilly, and J. E. Parillo. 1991. Endotoxemia in human septic shock. Chest 99:169–175.
   PubMed Web of Science ®Google Scholar
• Ernst, M. B., C. M. Wunderlich, S. Hess, M. Paehler, A. Mesaros, S. B. Koralov, A. Kleinridders, A. Husch, H. Munzberg, B. Hampel, J. Alber, P. Kloppenburg, J. C. Bruning, and F. T. Wunderlich. 2009. Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J. Neurosci. 29:11582–11593.
   PubMedGoogle Scholar
• Finco, T. S., A. A. Beg, and A. S. Baldwin, Jr. 1994. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U. S. A. 91:11884–11888.
   PubMed Web of Science ®Google Scholar
• Fukao, T., and S. Koyasu. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24:358–363.
   PubMed Web of Science ®Google Scholar
• Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowaki, T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:875–881.
   PubMed Web of Science ®Google Scholar
• Fukao, T., T. Yamada, M. Tanabe, Y. Terauchi, T. Ota, T. Takayama, T. Asano, T. Takeuchi, T. Kadowaki, J. Hata Ji, and S. Koyasu. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3:295–304.
   PubMedGoogle Scholar
• Gratton, J. P., M. Morales-Ruiz, Y. Kureishi, D. Fulton, K. Walsh, and W. C. Sessa. 2001. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276:30359–30365.
   PubMed Web of Science ®Google Scholar
• Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124–32132.
   PubMed Web of Science ®Google Scholar
• Guha, M., M. A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S. F. Yan, D. Stern, and N. Mackman. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429–1439.
   PubMed Web of Science ®Google Scholar
• Hall, A. J., H. L. Vos, and R. M. Bertina. 1999. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation. J. Biol. Chem. 274:376–383.
   PubMed Web of Science ®Google Scholar
• Hambleton, J., S. L. Weinstein, L. Lem, and A. L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. U. S. A. 93:2774–2778.
   PubMed Web of Science ®Google Scholar
• Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811.
   PubMed Web of Science ®Google Scholar
• Hoffmann, A., A. Levchenko, M. L. Scott, and D. Baltimore. 2002. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298:1241–1245.
   PubMed Web of Science ®Google Scholar
• Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18:6867–6874.
   PubMed Web of Science ®Google Scholar
• Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621–663.
   PubMed Web of Science ®Google Scholar
• Kim, A. H., G. Khursigara, X. Sun, T. F. Franke, and M. V. Chao. 2001. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:893–901.
   PubMed Web of Science ®Google Scholar
• Reference deleted.
   Google Scholar
• Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583–591.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191–202.
   PubMed Web of Science ®Google Scholar
• Lawrence, T., M. Bebien, G. Y. Liu, V. Nizet, and M. Karin. 2005. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434:1138–1143.
   PubMed Web of Science ®Google Scholar
• Li, Q., Q. Lu, V. Bottero, G. Estepa, L. Morrison, F. Mercurio, and I. M. Verma. 2005. Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc. Natl. Acad. Sci. U. S. A. 102:12425–12430.
   PubMedGoogle Scholar
• Liu, M. K., P. Herrera-Velit, R. W. Brownsey, and N. E. Reiner. 1994. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:2642–2652.
   PubMed Web of Science ®Google Scholar
• Liu, Z. G. 2005. Molecular mechanism of TNF signaling and beyond. Cell Res. 15:24–27.
   PubMed Web of Science ®Google Scholar
• Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6:777–784.
   PubMed Web of Science ®Google Scholar
• Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135–145.
   PubMed Web of Science ®Google Scholar
• Monick, M. M., A. B. Carter, P. K. Robeff, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake. 2001. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 166:4713–4720.
   PubMed Web of Science ®Google Scholar
• Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747–1754.
   PubMed Web of Science ®Google Scholar
• Muroi, M., and K. Tanamoto. 2008. TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB. J. Leukoc. Biol. 83:702–707.
   PubMedGoogle Scholar
• Reference deleted.
   Google Scholar
• Nakamura, K., H. Sakaue, A. Nishizawa, Y. Matsuki, H. Gomi, E. Watanabe, R. Hiramatsua, M. Tamamori-Adachi, S. Kitajima, T. Noda, W. Ogawa, and M. Kasuga. 2008. PDK1 regulates cell proliferation and cell cycle progression through control of cyclin D1 and p27Kip1 expression. J. Biol. Chem. 283:17702–17711.
   PubMed Web of Science ®Google Scholar
• Park, H. S., M. S. Kim, S. H. Huh, J. Park, J. Chung, S. S. Kang, and E. J. Choi. 2002. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277:2573–2578.
   PubMedGoogle Scholar
• Plum, L., B. F. Belgardt, and J. C. Bruning. 2006. Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 116:1761–1766.
   PubMed Web of Science ®Google Scholar
• Plum, L., X. Ma, B. Hampel, N. Balthasar, R. Coppari, H. Munzberg, M. Shanabrough, D. Burdakov, E. Rother, R. Janoschek, J. Alber, B. F. Belgardt, L. Koch, J. Seibler, F. Schwenk, C. Fekete, A. Suzuki, T. W. Mak, W. Krone, T. L. Horvath, F. M. Ashcroft, and J. C. Bruning. 2006. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest. 116:1886–1901.
   PubMedGoogle Scholar
• Pullen, N., P. B. Dennis, M. Andjelkovic, A. Dufner, S. C. Kozma, B. A. Hemmings, and G. Thomas. 1998. Phosphorylation and activation of p70s6k by PDK1. Science 279:707–710.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun. 2008. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9:369–377.
   PubMed Web of Science ®Google Scholar
• Srivastava, A. K., and S. K. Pandey. 1998. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell. Biochem. 182:135–141.
   PubMedGoogle Scholar
• Tanaka, H., N. Fujita, and T. Tsuruo. 2005. 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling. J. Biol. Chem. 280:40965–40973.
   PubMed Web of Science ®Google Scholar
• Trompouki, E., E. Hatzivassiliou, T. Tsichritzis, H. Farmer, A. Ashworth, and G. Mosialos. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793–796.
   PubMed Web of Science ®Google Scholar
• Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437–457.
   PubMed Web of Science ®Google Scholar
• Van Heel, D. A., D. P. McGovern, and D. P. Jewell. 2001. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357:1902–1904.
   PubMed Web of Science ®Google Scholar
• Wertz, I. E., K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, A. Ma, E. V. Koonin, and V. M. Dixit. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694–699.
   PubMed Web of Science ®Google Scholar
• Wick, K. L., and F. Liu. 2001. A new molecular target of insulin action: regulating the pivotal PDK1. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1:209–221.
   PubMedGoogle Scholar
• Williams, M. R., J. S. Arthur, A. Balendran, J. van der Kaay, V. Poli, P. Cohen, and D. R. Alessi. 2000. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:439–448.
   PubMed Web of Science ®Google Scholar
• Zhang, J., B. Stirling, S. T. Temmerman, C. A. Ma, I. J. Fuss, J. M. Derry, and A. Jain. 2006. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116:3042–3049.
   PubMed Web of Science ®Google Scholar